Cargando…

The dog as a naturally-occurring model for insulin-like growth factor type 1 receptor-overexpressing breast cancer: an observational cohort study

BACKGROUND: Dogs spontaneously develop invasive mammary carcinoma with a high prevalence of the triple-negative (TN) subtype (lack of ER-Estrogen Receptor and PR-Progesterone Receptor expression, lack of HER2-Human Epidermal Growth Factor Receptor 2 overexpression), making this animal model relevant...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaillardon, Laetitia, Abadie, Jérome, Godard, Tiffanie, Campone, Mario, Loussouarn, Delphine, Siliart, Brigitte, Nguyen, Frédérique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598970/
https://www.ncbi.nlm.nih.gov/pubmed/26449867
http://dx.doi.org/10.1186/s12885-015-1670-6
_version_ 1782394165134360576
author Jaillardon, Laetitia
Abadie, Jérome
Godard, Tiffanie
Campone, Mario
Loussouarn, Delphine
Siliart, Brigitte
Nguyen, Frédérique
author_facet Jaillardon, Laetitia
Abadie, Jérome
Godard, Tiffanie
Campone, Mario
Loussouarn, Delphine
Siliart, Brigitte
Nguyen, Frédérique
author_sort Jaillardon, Laetitia
collection PubMed
description BACKGROUND: Dogs spontaneously develop invasive mammary carcinoma with a high prevalence of the triple-negative (TN) subtype (lack of ER-Estrogen Receptor and PR-Progesterone Receptor expression, lack of HER2-Human Epidermal Growth Factor Receptor 2 overexpression), making this animal model relevant for investigating new therapeutic pathways. Insulin-like growth factor Type-1 receptor (IGF1R) is frequently overexpressed in primary human breast cancers, with a growing role in the TN phenotype. The purpose of this study was to investigate the Dog as a candidate model for IGF1R-overexpressing mammary carcinoma. METHODS: 150 bitches with canine mammary carcinoma (CMC) and a known 2-year follow-up were retrospectively included. IGF1R expression was assessed by immunohistochemistry (IHC) using a similar scoring system as for HER2 in breast cancer. The prognostic value of the IGF1R expression was assessed in terms of overall and specific survival as well as disease-free interval (DFI). RESULTS: 47 CMC (31 %) were classified as luminal and 103 (69 %) as triple-negative (TN-CMC). 41 % of CMC overexpressed IGF1R (IHC score 3+) of which 76 % were TN-CMC and 62 % grade III. IGF1R overexpression was associated with aggressive features including lymphovascular invasion, histological grade III, low ER expression and the TN phenotype. Univariate and multivariate analyses revealed that IGF1R overexpression was associated with shorter overall and specific survivals and shorter DFI in TN-CMC. CONCLUSIONS: IGF1R overexpression is common and related to a poor outcome in canine invasive mammary carcinoma, particularly in the triple negative subtype, as in human breast cancer. Preclinical studies using the Dog as a spontaneous animal model could be considered to investigate new therapies targeting IGF1R in triple-negative breast cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1670-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4598970
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45989702015-10-09 The dog as a naturally-occurring model for insulin-like growth factor type 1 receptor-overexpressing breast cancer: an observational cohort study Jaillardon, Laetitia Abadie, Jérome Godard, Tiffanie Campone, Mario Loussouarn, Delphine Siliart, Brigitte Nguyen, Frédérique BMC Cancer Research Article BACKGROUND: Dogs spontaneously develop invasive mammary carcinoma with a high prevalence of the triple-negative (TN) subtype (lack of ER-Estrogen Receptor and PR-Progesterone Receptor expression, lack of HER2-Human Epidermal Growth Factor Receptor 2 overexpression), making this animal model relevant for investigating new therapeutic pathways. Insulin-like growth factor Type-1 receptor (IGF1R) is frequently overexpressed in primary human breast cancers, with a growing role in the TN phenotype. The purpose of this study was to investigate the Dog as a candidate model for IGF1R-overexpressing mammary carcinoma. METHODS: 150 bitches with canine mammary carcinoma (CMC) and a known 2-year follow-up were retrospectively included. IGF1R expression was assessed by immunohistochemistry (IHC) using a similar scoring system as for HER2 in breast cancer. The prognostic value of the IGF1R expression was assessed in terms of overall and specific survival as well as disease-free interval (DFI). RESULTS: 47 CMC (31 %) were classified as luminal and 103 (69 %) as triple-negative (TN-CMC). 41 % of CMC overexpressed IGF1R (IHC score 3+) of which 76 % were TN-CMC and 62 % grade III. IGF1R overexpression was associated with aggressive features including lymphovascular invasion, histological grade III, low ER expression and the TN phenotype. Univariate and multivariate analyses revealed that IGF1R overexpression was associated with shorter overall and specific survivals and shorter DFI in TN-CMC. CONCLUSIONS: IGF1R overexpression is common and related to a poor outcome in canine invasive mammary carcinoma, particularly in the triple negative subtype, as in human breast cancer. Preclinical studies using the Dog as a spontaneous animal model could be considered to investigate new therapies targeting IGF1R in triple-negative breast cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1670-6) contains supplementary material, which is available to authorized users. BioMed Central 2015-10-08 /pmc/articles/PMC4598970/ /pubmed/26449867 http://dx.doi.org/10.1186/s12885-015-1670-6 Text en © Jaillardon et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Jaillardon, Laetitia
Abadie, Jérome
Godard, Tiffanie
Campone, Mario
Loussouarn, Delphine
Siliart, Brigitte
Nguyen, Frédérique
The dog as a naturally-occurring model for insulin-like growth factor type 1 receptor-overexpressing breast cancer: an observational cohort study
title The dog as a naturally-occurring model for insulin-like growth factor type 1 receptor-overexpressing breast cancer: an observational cohort study
title_full The dog as a naturally-occurring model for insulin-like growth factor type 1 receptor-overexpressing breast cancer: an observational cohort study
title_fullStr The dog as a naturally-occurring model for insulin-like growth factor type 1 receptor-overexpressing breast cancer: an observational cohort study
title_full_unstemmed The dog as a naturally-occurring model for insulin-like growth factor type 1 receptor-overexpressing breast cancer: an observational cohort study
title_short The dog as a naturally-occurring model for insulin-like growth factor type 1 receptor-overexpressing breast cancer: an observational cohort study
title_sort dog as a naturally-occurring model for insulin-like growth factor type 1 receptor-overexpressing breast cancer: an observational cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598970/
https://www.ncbi.nlm.nih.gov/pubmed/26449867
http://dx.doi.org/10.1186/s12885-015-1670-6
work_keys_str_mv AT jaillardonlaetitia thedogasanaturallyoccurringmodelforinsulinlikegrowthfactortype1receptoroverexpressingbreastcanceranobservationalcohortstudy
AT abadiejerome thedogasanaturallyoccurringmodelforinsulinlikegrowthfactortype1receptoroverexpressingbreastcanceranobservationalcohortstudy
AT godardtiffanie thedogasanaturallyoccurringmodelforinsulinlikegrowthfactortype1receptoroverexpressingbreastcanceranobservationalcohortstudy
AT camponemario thedogasanaturallyoccurringmodelforinsulinlikegrowthfactortype1receptoroverexpressingbreastcanceranobservationalcohortstudy
AT loussouarndelphine thedogasanaturallyoccurringmodelforinsulinlikegrowthfactortype1receptoroverexpressingbreastcanceranobservationalcohortstudy
AT siliartbrigitte thedogasanaturallyoccurringmodelforinsulinlikegrowthfactortype1receptoroverexpressingbreastcanceranobservationalcohortstudy
AT nguyenfrederique thedogasanaturallyoccurringmodelforinsulinlikegrowthfactortype1receptoroverexpressingbreastcanceranobservationalcohortstudy
AT jaillardonlaetitia dogasanaturallyoccurringmodelforinsulinlikegrowthfactortype1receptoroverexpressingbreastcanceranobservationalcohortstudy
AT abadiejerome dogasanaturallyoccurringmodelforinsulinlikegrowthfactortype1receptoroverexpressingbreastcanceranobservationalcohortstudy
AT godardtiffanie dogasanaturallyoccurringmodelforinsulinlikegrowthfactortype1receptoroverexpressingbreastcanceranobservationalcohortstudy
AT camponemario dogasanaturallyoccurringmodelforinsulinlikegrowthfactortype1receptoroverexpressingbreastcanceranobservationalcohortstudy
AT loussouarndelphine dogasanaturallyoccurringmodelforinsulinlikegrowthfactortype1receptoroverexpressingbreastcanceranobservationalcohortstudy
AT siliartbrigitte dogasanaturallyoccurringmodelforinsulinlikegrowthfactortype1receptoroverexpressingbreastcanceranobservationalcohortstudy
AT nguyenfrederique dogasanaturallyoccurringmodelforinsulinlikegrowthfactortype1receptoroverexpressingbreastcanceranobservationalcohortstudy